Increasing Number of Biopharmaceutical Products Qualified with National Standards

A total number of biopharmaceutical products that are qualified under the national standards has now increased to 13 items, according to a recent announcement by the Korea Food and Drug Administration (KFDA).

A new list of biopharmaceutical products that are now meeting the national standards include hepatitis B surface antigen, recombinant interferon alpha-2a, and prekallikrein activation...